"We are told by the insurer what to prescribe to the patient. After they fail methotrexate, it's a TNF inhibitor, almost always Humira. And that's not OK." If there's a shred of hope in this story, it ...

Humira is a brand-name drug that’s prescribed for several autoimmune conditions. It contains the active ingredient adalimumab. It isn’t known whether Humira is safe to use during pregnancy or ...

Daily oral treatment with T-614, a member of the methanesulfonanilide family of cyclo-oxygenase 2 inhibitors, might be an alternative to weekly methotrexate therapy for rheumatoid arthritis (RA).

Beyond early-stage rheumatoid arthritis in the hands, some people experience RA that can damage other body systems, including ...

AbbVie holds a strong portfolio of marketed and pipeline drugs. While the increasing competition to the company's key drug Humira should slow the growth for the company in the near term ...

Methotrexate 1g/vial; pwd for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection ...

Opinions expressed by Forbes Contributors are their own. Joshua Cohen is a Boston-based writer who covers health policy. In a unique challenge to drug makers, the Dutch Pharmaceutical ...

Novartis has launched two trials pitching Cosentyx head-to-head with AbbVie’s Humira and one of its own biosimilars in a bid to increase its presence in a highly competitive market. Cosentyx ...

After years of patent protection, biosimilars for Humira are set to enter the US market in 2023. The arrival of these drugs has been widely anticipated throughout the healthcare industry.

Psoriasis is a chronic skin disorder characterized by epidermal hyperproliferation and dermal inflammation that vary in severity, from minor, localized patches to complete body coverage.

It's official! UnitedHealth's Optum Rx pharmacy benefit manager unit will not be a haven for employers and workers who love Humira. The PBM told sponsors of commercial plans in August that it ...

UnitedHealth Group's Optum Rx will join its peers in the big three pharmacy benefit managers by pulling Humira from some of its preferred formularies, according to a report from Reuters.